Spruce Biosciences, Inc. Common Stock (SPRB) — Cash Flow Reinvestment Rate
Latest as of June 2023:
11.04x
Spruce Biosciences, Inc. Common Stock (SPRB) has a Cash Flow Reinvestment Rate of 11.04x as of June 2023, reinvesting $22.00 Million (capex $0.00 plus investments $22.00 Million) from operating cash flow of $1.99 Million. See SPRB FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
11.04x
(Capex + Investments) / Operating CF
Total Reinvested
$22.00 Million
Capex + Investments
Operating Cash Flow
$1.99 Million
USD
Capital Expenditures
$0.00
USD
Annual Cash Flow Reinvestment Rate for Spruce Biosciences, Inc. Common Stock (None–None)
Year-by-year capital reinvestment analysis for Spruce Biosciences, Inc. Common Stock. See Spruce Biosciences, Inc. Common Stock financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow